| scholarly article | Q13442814 |
| P50 | author | Volodymyr Tryndyak | Q55446237 |
| P2093 | author name string | Ivan Rusyn | |
| Beverly Montgomery | |||
| Igor P Pogribny | |||
| Stepan Melnyk | |||
| Tetyana V Bagnyukova | |||
| Anna Boureiko | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium | Q28255368 | ||
| The epigenomics of cancer | Q28289975 | ||
| Non-transcriptional control of DNA replication by c-Myc | Q28307758 | ||
| Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression | Q28379242 | ||
| Mobile elements: drivers of genome evolution | Q29547669 | ||
| The history of cancer epigenetics | Q29617273 | ||
| Thoughts on carcinogenesis testing: the FDA today | Q33896252 | ||
| Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis | Q34016094 | ||
| A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands | Q78202642 | ||
| The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations | Q80166961 | ||
| Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice | Q82827752 | ||
| Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization | Q34061084 | ||
| Altered DNA methylation: a secondary mechanism involved in carcinogenesis | Q34504084 | ||
| Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. | Q34574880 | ||
| Active cytosine demethylation triggered by a nuclear receptor involves DNA strand breaks. | Q34983814 | ||
| The long (LINEs) and the short (SINEs) of it: altered methylation as a precursor to toxicity | Q35139647 | ||
| Mechanisms of DNA Damage, DNA Hypomethylation, and Tumor Progression in the Folate/Methyl-Deficient Rat Model of Hepatocarcinogenesis | Q35579915 | ||
| PPARalpha agonist-induced rodent tumors: modes of action and human relevance | Q35631058 | ||
| Epigenetics and cancer: implications for drug discovery and safety assessment | Q35749946 | ||
| Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis | Q35830218 | ||
| Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma | Q35945177 | ||
| Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha. | Q36202782 | ||
| The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). | Q36328530 | ||
| Molecular mechanisms of human carcinogenesis | Q36355761 | ||
| Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. | Q36586072 | ||
| DNA hypomethylation and human diseases. | Q36625537 | ||
| Epigenetic processes and cancer risk assessment | Q36674390 | ||
| Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents | Q36945640 | ||
| Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state | Q36950762 | ||
| PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators | Q37002053 | ||
| Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements | Q39695383 | ||
| Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. | Q40599799 | ||
| Quantification of 3'OH DNA breaks by random oligonucleotide-primed synthesis (ROPS) assay | Q41223814 | ||
| Influence of oxygen radical injury on DNA methylation. | Q41439646 | ||
| Large-scale structure of genomic methylation patterns | Q42186756 | ||
| Wy-14,643-induced hypomethylation of the c-myc gene in mouse liver | Q43635306 | ||
| Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice | Q44285111 | ||
| Progressive alterations in global and GC-rich DNA methylation during tumorigenesis | Q44527204 | ||
| Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators | Q44761807 | ||
| DNA hypomethylation induced by drinking water disinfection by-products in mouse and rat kidney | Q46598686 | ||
| Global DNA hypomethylation in liver cancer cases and controls: a phase I preclinical biomarker development study. | Q46886305 | ||
| Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. | Q51579160 | ||
| Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. | Q53342403 | ||
| Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis. | Q53413487 | ||
| Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. | Q53519250 | ||
| Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. | Q53536112 | ||
| Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. | Q54451004 | ||
| Di-(2-ethylhexyl)phthalate: An industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rats and mice | Q67455009 | ||
| Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations | Q73406154 | ||
| Hypomethylation of the rat glutathione S-transferase pi (GSTP) promoter region isolated from methyl-deficient livers and GSTP-positive liver neoplasms | Q77322498 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17-23 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Mutation Research | Q6943732 |
| P1476 | title | Mechanisms of peroxisome proliferator-induced DNA hypomethylation in rat liver | |
| P478 | volume | 644 |
| Q28389548 | A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide |
| Q35552256 | Aging and DNA methylation |
| Q36245143 | Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer |
| Q46962996 | Changes of c-Myc and DNMT1 mRNA and protein levels in the rat livers induced by dibutyl phthalate treatment |
| Q89342751 | DNA methylation of imprinted genes in Mexican-American newborn children with prenatal phthalate exposure |
| Q46262957 | Defining baseline epigenetic landscapes in the rat liver |
| Q39456771 | Derisking Drug-Induced Carcinogenicity for Novel Therapeutics |
| Q43053706 | Di-butyl phthalate-induced hypomethylation of the c-myc gene in rat liver |
| Q43119641 | Dynamic effect of di-2-(ethylhexyl) phthalate on testicular toxicity: epigenetic changes and their impact on gene expression |
| Q43242687 | Dynamic epigenetic changes involved in testicular toxicity induced by di-2-(ethylhexyl) phthalate in mice |
| Q57970772 | Epigenomics - Impact for Drug Safety Sciences |
| Q28578058 | Evaluation of in vivo liver genotoxic potential of Wy-14,643 and piperonyl butoxide in rats subjected to two-week repeated oral administration |
| Q42856152 | Functional Role of Phospholipase D (PLD) in Di(2-Ethylhexyl) Phthalate-Induced Hepatotoxicity in Sprague-Dawley Rats |
| Q35878556 | Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds |
| Q42712173 | Global and MGMT promoter hypomethylation independently associated with genomic instability of lymphocytes in subjects exposed to high-dose polycyclic aromatic hydrocarbon. |
| Q38156610 | In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors. |
| Q34601385 | Interstrain differences in the liver effects of trichloroethylene in a multistrain panel of inbred mice |
| Q28394822 | Maternal phthalate exposure during pregnancy is associated with DNA methylation of LINE-1 and Alu repetitive elements in Mexican-American children |
| Q37962000 | MicroRNA dysregulation during chemical carcinogenesis |
| Q34350520 | Perfluorooctanoic acid (PFOA) acts as a tumor promoter on Syrian hamster embryo (SHE) cells |
| Q38797903 | Prenatal phthalate exposure: epigenetic changes leading to lifelong impact on steroid formation |
| Q37865527 | Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment |
| Q38889150 | Role of fumonisin B1 on DNA methylation changes in rat kidney and liver cells |
| Q40120392 | The combined effects of DEHP and PCBs on phospholipase in the livers of mice |
| Q64880869 | Tissue-specific changes in Srebf1 and Srebf2 expression and DNA methylation with perinatal phthalate exposure. |
| Q43276103 | Vitamin C and resveratrol supplementation to rat dams treated with di(2-ethylhexyl)phthalate: impact on reproductive and oxidative stress end points in male offspring. |
Search more.